Using cut-off values of C-reactive protein (CRP) concentrations greater than 150 mg/L or ferritin concentrations greater than 1,500 μg/L, Manson JJ and colleagues (62) recently described an hyperinflammatory phenotype of COVID-19 characterized by poor clinical outcomes irrespective of other demographic and clinical variables. This evidence concerns the gene CRP and COVID-19.